Lispro NL-ELISA
Lispro NL-ELISA
(10-1291-01)
Kit format: 1 x 96 wells
Measurement range: 1 - 500 mU/L
Optimized for pharma use
No cross-reactivity to endogenous insulin or other insulin analogs e.g. glargine
No interference from insulin auto-antibodies
Fully validated for use with human and pig samples, partially validated for rat samples
Controls included in the kit
Mercodia Lispro NL-ELISA is designed to be an excellent assay for pharma use.
The Mercodia Lispro NL-ELISA provides a chemiluminescent method for the quantitative determination of insulin lispro. The kit includes six calibrators, two anchor points and controls in serum matrix. Validation data available.
Human and Porcine
Serum, EDTA plasma and P-800 plasma
10 µL
1 - 500 mU/L
≤0.36 mU/L
1h + 1h + 10 min
Chemiluminescence
The following cross-reactions have been tested:
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
| LOT. NO. | DOCUMENT |
|---|---|
| 32438 | DfU - 10-1291-01 v. 3.0 |
| LOT. NO. | DOCUMENT |
|---|---|
| 32438 | CoA - 10-1291-01 |
For other languages and previous versions: Technical Library
Question about the product? Contact us
Area Sales Manager Denmark, Iceland, Norway and Sweden
robert.almstedt@mercodia.com (+46) 72 292 15 08 BOOK A MEETING